Kinematic-based BoNT-A Injections for Bilateral ET
Status:
Active, not recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
The primary objective is to study the efficacy of botulinum toxin type A (Xeomin®) injected
utilizing kinematically-based injection parameters for the treatment of upper extremity
essential tremor (ET). Additional objectives are to study the benefit of kinematic assessment
tools in determining injection parameters and to study the composition of tremor using
kinematics.
Phase:
Phase 2
Details
Lead Sponsor:
Western University, Canada
Treatments:
abobotulinumtoxinA Botulinum Toxins Botulinum Toxins, Type A incobotulinumtoxinA onabotulinumtoxinA